Caribou Biosciences (CRBU) Other Working Capital Changes (2020 - 2026)
Caribou Biosciences' (CRBU) quarterly Other Working Capital Changes came in at -$1.0 million in Q1 2026, down 282.13% year-on-year from $551805.8 in Q1 2025, and down 189.49% on a QoQ basis from $1.1 million in Q4 2025.
Caribou Biosciences (CRBU) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 6 years of Other Working Capital Changes data on file, last reported at -$1.0 million in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 282.13% year-over-year to -$1.0 million in Q1 2026; TTM through Mar 2026 was -$2.1 million, a 0.92% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, up 46.1% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$1.0 million, down from $1.1 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for CRBU reached as high as $3.0 million in Q3 2024 and fell as low as -$1.9 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged -$61941.2 across 5 years, with a median of -$62000.0 in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 704.12% in 2023 and fell as far as 1190.59% in 2023.
- Year by year, Other Working Capital Changes stood at $2.9 million in 2022, then sank by 121.09% to -$606000.0 in 2023, then tumbled by 235.97% to -$2.0 million in 2024, then soared by 155.16% to $1.1 million in 2025, then sank by 189.49% to -$1.0 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$1.0 million in Q1 2026, $1.1 million in Q4 2025, and -$627000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -522,000.00 |
| Mar 31, 2026 | -522,000.00 |
| Mar 31, 2026 | -522,000.00 |
| Dec 31, 2025 | -1.93 Mn |
| Dec 31, 2025 | -1.93 Mn |
| Dec 31, 2025 | -1.93 Mn |
| Sep 30, 2025 | -930,000.00 |
| Sep 30, 2025 | -930,000.00 |
| Sep 30, 2025 | -930,000.00 |
| Jun 30, 2025 | -340,000.00 |
| Jun 30, 2025 | -340,000.00 |
| Jun 30, 2025 | -340,000.00 |
| Mar 31, 2025 | -471,000.00 |
| Mar 31, 2025 | -471,000.00 |
| Mar 31, 2025 | -471,000.00 |
| Dec 31, 2024 | 780,000.00 |
| Dec 31, 2024 | 780,000.00 |
| Dec 31, 2024 | 780,000.00 |
| Sep 30, 2024 | 2.99 Mn |
| Sep 30, 2024 | 2.99 Mn |